Groningen

• Quantitative Fluorescence molecular imaging in Crohn’s disease and psoriasis Recruiting
  2023-506192-10-00 1 2025-02-14 Crohn's disease
• Molecular signatures associated with response to ICS treatment in patients with COPD stratified by eosinophil levels Recruiting
  2023-505245-13-00 6 2025-02-12 Chronic obstructive pulmonary disease (COPD)
• Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors Recruiting
  2023-509632-26-00 9 2025-02-11 Recurrent or Metastatic Solid Tumors (endometrial cancer (EC); head an
• Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Ca … Recruiting
  2022-502352-31-00 5 2025-02-10 Colorectal Cancer (CRC)
• A first-in-human study to determine the safety and tolerability of different doses of GEH200520 Injection and GEH200521 (18F) Injection and … Recruiting
  2024-515218-42-00 1 2025-01-23 Irresectable or metastatic solid tumour or a local and resectable head
• Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trial Recruiting
  2024-514615-10-01 9 2025-01-14 Subarachnoid hemorrhage
• Takeda Brentuximab; Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate brentuximab biodistribution in CD30-posit … Recruiting
  2024-511151-18-01 3 2025-01-02 Patients with stage II-IV high risk diffuse large B-cell lymphoma, def
• Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma Recruiting
  2024-511188-26-00 5 2024-12-20 Relapsed/refractory multiple myeloma in patients who have received 1 t
• Safe Stop Trial Melanoma Recruiting
  2024-516937-10-01 5 2024-12-18 Melanoma
• Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h … Recruiting
  2023-509717-36-00 5 2024-12-16 AF patients who have undergone successful PCI
• Inventarisation of the value of FAPI and FDG-PET-CT in the diagnosis of acute phase Peyronie’s Disease Recruiting
  2024-518838-82-00 6 2024-12-13 Peyronie's Disease
• A clinical trial to learn about the effects of YTB in people with difficult to treat active systemic lupus erythematosus (SLE), or active k … Recruiting
  2023-510150-17-00 4 2024-12-11 Active, refractory systemic lupus erythematosus (SLE), and active, re
• Positron emission tomography with macrophage targeting to select individuals at risk for rheumatoid arthritis. Recruiting
  2024-513538-40-02 4 2024-12-09 ACPA positive arthralgia
• Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting
  2024-513092-40-00 6 2024-12-05 Stroke
• Oil- based versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized c … Recruiting
  2024-512571-12-00 6 2024-11-29 Infertility
• PET-imaging of two Vartumabs (F8scFv and C9scFv) in patients with solid tumors – a Phase 0 basket trial Recruiting
  2024-513827-18-00 1 2024-11-29 Multiple solid tumors including: colorectal carcinoma (CRC), pancreati
• A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting
  2023-508191-11-00 5 2024-11-28 Systemic lupus erythematosus (SLE)
• Iberdomide combined with low-dose cyclophosphamide and dexamethasone: ICON study Recruiting
  2023-508902-66-00 4 2024-11-28 relapsed / refractory multiple myeloma
• [18F]PEG-folate PET-CT imaging for monitoring of therapy response in Rheumatoid Arthritis patients Recruiting
  2024-513537-21-02 4 2024-11-27 Rheumatoid Arthritis
• LAG3 PET; ImmunoPET imaging with 89Zr-DFO-REGN3767 in patients with advanced solid cancer prior to and during treatment with cemiplimab with … Recruiting
  2024-516795-15-00 4 2024-11-27 Metastatic solid tumors, these may include but are not limited to mela
• Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan. Recruiting
  2024-514489-38-01 4 2024-11-26 giant cell arteritis
• Detection of tumor tiSsue in pEritoneal metastases of coLorectal origin using a VEGF-targeted optical fluoresCent imaging tracer during diag … Recruiting
  2024-517718-13-01 3 2024-11-25 peritoneal metastases of colorectal origin
• Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study Recruiting
  2024-518878-14-01 6 2024-11-25 Inflammatory bowel disease
• [68Ga]-FAPI PET/CT to visualize the activity of fibrogenic cells in patients with non-resolving shock lung. Recruiting
  2024-517257-27-00 11 2024-11-24 Non-resolving ARDS

Showing 193–216 of 679 trials